Loading institutional data...
Loading institutional data...
Held by 232 of 5,944 reporting institutions (93th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $68.61 today, the market must believe free cash flow compounds 10.1%/yr for a decade (off $56M normalized FCF).
The market's 10.1% is more conservative than its 9-yr track record.
2-stage DCF · 0.02B shares · net debt $71M
mean 74.6% · volatility σ 146% · implied rate exceeded in 5/9 yrs
Central path = implied 10.1%/yr growth; shaded band = ±1σ (146%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $463.1M 100.0% | $360.7M 100.0% | $325.1M 100.0% | $321.2M 100.0% | $445.5M 100.0% | $405.1M 100.0% | $362.0M 100.0% | $332.7M 100.0% | $285.8M 100.0% | $206.2M 100.0% |
| Cost of Revenue | $198.7M 42.9% | $159.1M 44.1% | $142.1M 43.7% | $143.4M 44.6% | $227.6M 51.1% | $215.1M 53.1% | $224.9M 62.1% | $190.1M 57.1% | $160.8M 56.3% | $105.7M 51.2% |
| Cost of Products | — | — | — | — | — | — | — | — | $160.9M 56.3% | $105.9M 51.3% |
| Gross Profit | $264.3M 57.1% | $201.6M 55.9% | $182.9M 56.3% | $177.8M 55.4% | $217.8M 48.9% | $190.0M 46.9% | $137.1M 37.9% | $142.6M 42.9% | $125.0M 43.7% | $100.5M 48.8% |
| Research & Development | $900K 0.2% | $1.3M 0.4% | $600K 0.2% | $600K 0.2% | $1.1M 0.2% | $1.3M 0.3% | $2.5M 0.7% | $2.5M 0.8% | $2.3M 0.8% | $2.0M 1.0% |
| Selling, General & Admin | $169.0M 36.5% | $122.4M 33.9% | $104.3M 32.1% | $103.8M 32.3% | $127.5M 28.6% | $125.6M 31.0% | $109.9M 30.4% | $94.1M 28.3% | $75.3M 26.3% | $56.6M 27.5% |
| Operating Income | $95.3M 20.6% | $80.8M 22.4% | $83.0M 25.5% | $74.0M 23.0% | $90.3M 20.3% | $64.4M 15.9% | $27.2M 7.5% | $48.5M 14.6% | $49.7M 17.4% | $43.9M 21.3% |
| Interest Expense | $25.4M 5.5% | $18.5M 5.1% | $21.0M 6.5% | $21.9M 6.8% | — | — | — | $15.1M 4.5% | $16.9M 5.9% | $26.7M 13.0% |
| Interest & Investment Income | $7.9M 1.7% | $4.5M 1.3% | $6.4M 2.0% | $2.4M 0.7% | — | $198K 0.0% | $2.6M 0.7% | $424K 0.1% | $438K 0.2% | $768K 0.4% |
| Pretax Income | $83.1M 18.0% | $65.0M 18.0% | $62.1M 19.1% | $42.1M 13.1% | $65.3M 14.7% | $50.1M 12.4% | $19.1M 5.3% | $31.6M 9.5% | $26.9M 9.4% | $14.9M 7.2% |
| Income Tax Expense | $15.0M 3.2% | $16.9M 4.7% | $24.0M 7.4% | $11.0M 3.4% | $14.0M 3.2% | $12.0M 3.0% | $2.9M 0.8% | $6.3M 1.9% | $7.3M 2.5% | -$12.0M -5.8% |
| Net Income | $58.2M 12.6% | $39.8M 11.0% | $38.5M 11.8% | $11.6M 3.6% | $52.1M 11.7% | $38.2M 9.4% | $16.2M 4.5% | $25.3M 7.6% | $20.2M 7.1% | $26.9M 13.1% |
| Per Share | ||||||||||
| EPS (Basic) | $3.18 | $2.24 | $2.19 | $0.65 | $2.75 | $1.97 | $0.83 | $1.31 | $1.06 | $1.63 |
| EPS (Diluted) | $3.11 | $2.14 | $2.01 | $0.64 | $2.52 | $1.85 | $0.78 | $1.28 | $1.04 | $1.49 |
| Weighted Avg Shares (Basic) | 18.3M | 17.7M | 17.6M | 17.9M | 18.9M | 19.4M | 19.6M | 19.4M | 19.0M | 16.5M |
| Weighted Avg Shares (Diluted) | 18.7M | 19.4M | 20.5M | 18.1M | 22.4M | 22.9M | 23.2M | 19.8M | 19.5M | 18.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 13% of free cash flow, leaving room to grow it and fund buybacks. Last year: $6M dividends + $0 buybacks = $6M returned on $44M FCF.
9 consecutive years of dividend increases · 29%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~8.6% on $294M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.5B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.2B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.9B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $346.8B | 22.7× | 16.4× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $296.4B | 26.2× | 17.3× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.0B | 22.3× | 14.9× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.7B | 16.9× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.3B | 32.8× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $72.4B | 19.7× | 10.5× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.3B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.5B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.7B | 20.5× | 14.3× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $42.6B | 39.5× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.0B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.7B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.6B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $34.2B | 23.5× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| HSY | $34.1B | — | 20.1× | 2.9× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $33.8B | — | 768.2× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.5B | 18.2× | 8.1× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.1B | 31.5× | 18.8× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| TPB | $1.3B | 22.1× | — | 2.7× | 28.4% | 57.1% | 12.6% | 15.6% | 8.7% | — | 232 |
Peers = companies sharing TPB's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 10-yr range · 47th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 10-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 57.1 | 62.1 | 53.1 | 51.1 | 44.6 | 43.7 | 44.1 | 42.9 |
| Gross Profit | 42.9 | 37.9 | 46.9 | 48.9 | 55.4 | 56.3 | 55.9 | 57.1 |
| R&D | 0.8 | 0.7 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 |
| SG&A | 28.3 | 30.4 | 31.0 | 28.6 | 32.3 | 32.1 | 33.9 | 36.5 |
| Operating Income | 14.6 | 7.5 | 15.9 | 20.3 | 23.0 | 25.5 | 22.4 | 20.6 |
| Income Tax | 1.9 | 0.8 | 3.0 | 3.2 | 3.4 | 7.4 | 4.7 | 3.2 |
| Net Income | 7.6 | 4.5 | 9.4 | 11.7 | 3.6 | 11.8 | 11.0 | 12.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TPB: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.